Looking to sell Synthego stock or options?
Synthego offers a precision genome engineering platform aimed at streamlining and enhancing the drug discovery research process. Utilizing informatics and machine learning, the platform delivers precision and automation in genome engineering. This enables genetic engineers and medical professionals to perform research quickly and cost-effectively while ensuring consistent outcomes.
Perceptive Advisors, Declaration Partners, Moore Strategic Ventures, Menlo Ventures, ZhenFund, AAF Management, Wellington Management, 8VC, Elements Capital Partners, GigaFund, AME Cloud Ventures, Tony Huang, SciFi VC, Moshen Chan, Chimera Capital, Intel Capital, Revelation Partners, Open Field Capital, Level One Fund, OS Fund, RA Capital Management, Founders Fund, Logos Capital, Alexandria Real Estate Equities, WI Harper Group.